Search Videos and More
Current State of Transcatheter Mitral Valve Therapies: The Common, Complex and Current Research at the Sentara Heart Valve Center in 2026
Dr. Summers reviews guideline-directed indications for transcatheter mitral interventions and examine real-world cases from the Sentara Structural Heart Program.Advances in ICD Technology: The AURORA Extravascular ICD System
Dr. Iyer discusses the patient selection process and implant procedure for the Aurora extravascular defibrillator.Right Heart Failure
Dr. Sudhan Nagarajan reviews RV pathophysiology and discusses management from a surgeon's perspective.Beyond ICD Shocks and Drugs: Modern Approaches to Ventricular Tachycardia Ablation
Dr. Div Patel discusses patient selection, mapping strategies and why VT remains a lethal condition even with ICDs and antiarrhythmics.Starting a Cardiology Fellowship: the Good, the Bad, and the Rewarding
Dr Sneha Vakamudi describes the strategy and leadership roles needed when structuring a cardiology fellowship program.Cardiovascular Disease and Obstructive Sleep Apnea
Dr. Benjamin D'Souza discusses the cardiovascular complications of obstructive sleep apnea and how to build a comprehensive screening practice for patients with undiagnosed obstructive sleep apnea.Computational Modeling and Advanced Pre-procedural Simulation to Guide Complex Structural Heart Interventions
Dr. Matthew Summers, Program Director of Structural Heart and Co-Director of the Sentara Heart Valve Center at Sentara, discusses the need for pre-procedural planning using computational modeling to guide treatment options for cardiac patient undergoing valve procedures at Sentara.Group 2 PH: The Overlooked Link Between Heart and Lung Health
Dr. Raymond Benza shares key insights from his ongoing work and discusses the evolving landscape of treatment for Group 2 pulmonary hypertension.Decreasing CHF Readmissions with Zoll HFMS: Sentara Virginia Beach General Hospital Pilot Study
Chelsea Christensen, PA with Sentara Cardiology Specialists, describes a patient monitoring protocol using radiofrequency technology to detect CHF symptoms to prevent hospital readmissions.Comparison of Chagas and Sarcoid Cardiomyopathy
Dr. Marcus describes prevalence of chagas disease and diagnosis ramifications.Understanding Group 2 Pulmonary Hypertension: Implications for Future Clinical Trials
Dr. Benza discusses the pathophysiology and management principles of Group 2 pulmonary hypertension.ICG Fluorescence: Advancing Thoracic Surgery
Dr. Raffaele Marchigiani demonstrates the use of Indocyanine Green (ICG) Fluorescence Imaging during a thoracic wedge resection.